ERIKA MORRIS: Open Payments
NPI 1821757568 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,835 in 117 payments from 16 companies in 2025. Trend: 2023 $39 · 2024 $2,431 · 2025 $2,835
Food & beverage: $2,835
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 62 | $1,134 |
| Amgen Inc. | 17 | $397 |
| Janssen Biotech, Inc. | 5 | $223 |
| GlaxoSmithKline, LLC. | 7 | $204 |
| UCB, Inc. | 3 | $142 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $130 |
| Novartis Pharmaceuticals Corporation | 5 | $119 |
| GENZYME CORPORATION | 1 | $118 |
| AstraZeneca Pharmaceuticals LP | 3 | $84 |
| Radius Health, Inc. | 3 | $74 |
Products named: RINVOQ, SKYRIZI, TREMFYA, BENLYSTA, TAVNEOS, Bimzelx, KRYSTEXXA, KEVZARA.
Industry payments across CA — which companies pay providers there.
